Paying With Corporate “Mini-Currencies” Once upon a time, a publicly-traded technology company (or a pharmaceutical — essentially, a special case of technology company) with $1 billion in sales and, say, $200 million in net income, might have earmarked $20 to $30 million annually for research and development (“R&D”). Today, it makes more financial sense for...Read More
“What’s .00001% x $315 Million?” I think I speak for bloggers everywhere reacting to the news that The Huffington Post sold to AOL for $315 million when I say: ‘CRAP!! THAT’S IT?!’ Reaction #2: ‘what’s .000001 x $315 million?’ (answer: $32, rounded up). The incredulity has to do with the eye-popping valuations being sported by...Read More
